A carregar...
TMC207: the first compound of a new class of potent anti-tuberculosis drugs
Disease caused by Mycobacterium tuberculosis continues as a global epidemic: over 2 billion people harbor latent TB infection, and more than 9 million new TB cases, of whom 500,000 are multidrug-resistant (MDR), and nearly 2 million deaths are estimated to occur each year. New drugs are required to...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921705/ https://ncbi.nlm.nih.gov/pubmed/20521931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fmb.10.50 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|